Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Dec 12, 2024

BUY
$6.19 - $8.78 $699 - $992
113 New
113 $0
Q3 2022

Dec 12, 2024

BUY
$6.5 - $12.67 $734 - $1,431
113 New
113 $0
Q2 2021

Aug 09, 2021

BUY
$32.22 - $44.59 $3,640 - $5,038
113 New
113 $4,000

Others Institutions Holding ADPT

About Adaptive Biotechnologies Corp


  • Ticker ADPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 142,872,992
  • Market Cap $873M
  • Description
  • Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...
More about ADPT
Track This Portfolio

Track Heritage Wealth Advisors Portfolio

Follow Heritage Wealth Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Heritage Wealth Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Heritage Wealth Advisors with notifications on news.